Výsledky vyhledávání - "Susanna J, Jacobus"

Multivariable Analyses of Prognostic Factors for Progression-Free Survival (PFS) and Complete Response (CR) with Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone Versus Rvd Plus Autologous Stem Cell Transplantation (ASCT) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the Determination Phase 3 Trial

Publikováno v: Blood. 140:4834-4838

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9d52f034244857128aa9c925065b6f0d
https://doi.org/10.1182/blood-2022-162741

Zobrazit plný text záznamu

Multivariable Analyses of Prognostic Factors for Progression-Free Survival (PFS) and Complete Response (CR) with Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone Versus Rvd Plus Autologous Stem Cell Transplantation (ASCT) and Lenalidomide (R) Maintenance to Progression in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the Determination Phase 3 Trial

Publikováno v: Transplantation and Cellular Therapy. 29:S396-S397

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b6bbd7357ec13946bddc028e217dad3a
https://doi.org/10.1016/s2666-6367(23)00598-5

Zobrazit plný text záznamu

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

Autor: Paul G, Richardson, Susanna J, Jacobus, Edie A, Weller, Hani, Hassoun, Sagar, Lonial, Noopur S, Raje, Eva, Medvedova, Philip L, McCarthy, Edward N, Libby, Peter M, Voorhees, Robert Z, Orlowski, Larry D, Anderson, Jeffrey A, Zonder, Carter P, Milner, Cristina, Gasparetto, Mounzer E, Agha, Abdullah M, Khan, David D, Hurd, Krisstina, Gowin, Rammurti T, Kamble, Sundar, Jagannath, Nitya, Nathwani, Melissa, Alsina, R Frank, Cornell, Hamza, Hashmi, Erica L, Campagnaro, Astrid C, Andreescu, Teresa, Gentile, Michaela, Liedtke, Kelly N, Godby, Adam D, Cohen, Thomas H, Openshaw, Marcelo C, Pasquini, Sergio A, Giralt, Jonathan L, Kaufman, Andrew J, Yee, Emma, Scott, Pallawi, Torka, Amy, Foley, Mariateresa, Fulciniti, Kyle, Hebert, Mehmet K, Samur, Kelly, Masone, Michelle E, Maglio, Andrea A, Zeytoonjian, Omar, Nadeem, Robert L, Schlossman, Jacob P, Laubach, Claudia, Paba-Prada, Irene M, Ghobrial, Aurore, Perrot, Philippe, Moreau, Hervé, Avet-Loiseau, Michel, Attal, Kenneth C, Anderson, Nikhil C, Munshi, Hillard, Lazarus

Publikováno v: N Engl J Med

BACKGROUND: In patients with newly diagnosed multiple myeloma, the effect of adding autologous stem-cell transplantation (ASCT) to triplet therapy (lenalidomide, bortezomib, and dexamethasone [RVD]), followed by lenalidomide maintenance therapy until

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0b1812b4562ddb28a8653ea20d6d6cf
https://pubmed.ncbi.nlm.nih.gov/35660812

Zobrazit plný text záznamu

Lenalidomide, bortezomib, and dexamethasone (RVd) ± autologous stem cell transplantation (ASCT) and R maintenance to progression for newly diagnosed multiple myeloma (NDMM): The phase 3 DETERMINATION trial

Publikováno v: Journal of Clinical Oncology. 40:LBA4-LBA4

LBA4 Background: Optimal use of triplet/quadruplet induction, ASCT, and R-based maintenance in patients (pts) with NDMM who are eligible for transplant continues to evolve. The IFM 2009 trial, which used R maintenance for 1 year (y), showed progressi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c5e2be4f76193773dbe5dca44c163da3
https://doi.org/10.1200/jco.2022.40.17_suppl.lba4

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání